Difference between revisions of "Team:KAIT JAPAN/contribution"

 
Line 15: Line 15:
 
<p><a href=http://parts.igem.org/wiki/index.php?title=Part:BBa_K2335003>BBa_K2335003</a></p>
 
<p><a href=http://parts.igem.org/wiki/index.php?title=Part:BBa_K2335003>BBa_K2335003</a></p>
 
<p><a href=http://parts.igem.org/wiki/index.php?title=Part:BBa_K2335004>BBa_K2335004</a></p>
 
<p><a href=http://parts.igem.org/wiki/index.php?title=Part:BBa_K2335004>BBa_K2335004</a></p>
 +
<br>
 +
<br>
 +
<br>
 +
<br>
 +
 
</main>
 
</main>
 
</html>
 
</html>
 
{{KAIT_JAPAN_footer}}
 
{{KAIT_JAPAN_footer}}

Latest revision as of 01:39, 2 November 2017

CONTRIBUTION

Our team did the following things this year.
1. We participated in the interLab study.

One in five people (more than 20 million people), have hay fever. The number of hay fever patients is expected to increase in the future. So we thought about creating a system to cure hay fever. This system senses IL-10 and produces IL-12.

2. To create Cure Allergy Rhinitis, we created and submitted the following five parts.

BBa_K2335005

BBa_K2335001

BBa_K2335002

BBa_K2335003

BBa_K2335004






Contact: kaitjapan@gmail.com Twitter:@KAIT_JAPAN Kanagawa Institute of Technology Metabologenomics.Inc Integrated DNA Technologies Promega Leave a Nest iDen